Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack
Open Access
- 3 March 2021
- journal article
- research article
- Published by Elsevier BV in Cell Reports Medicine
- Vol. 2 (3), 100209
- https://doi.org/10.1016/j.xcrm.2021.100209
Abstract
No abstract availableKeywords
Funding Information
- Austrian Research Promotion Agency
- Swiss National Science Foundation
This publication has 100 references indexed in Scilit:
- Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in ManScience Translational Medicine, 2012
- Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple SpeciesScience Translational Medicine, 2012
- Viral Vector-Based Therapeutic Cancer VaccinesThe Cancer Journal, 2011
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate CancerThe New England Journal of Medicine, 2010
- Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunityNature Medicine, 2010
- Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humansNature Medicine, 2009
- Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interestProceedings of the National Academy of Sciences of the United States of America, 2009
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysisThe Lancet, 2008
- Genome comparison of virulent and avirulent strains of the Pichinde arenavirusArchiv für die gesamte Virusforschung, 2008
- Inflammation Directs Memory Precursor and Short-Lived Effector CD8+ T Cell Fates via the Graded Expression of T-bet Transcription FactorImmunity, 2007